New polycyclic indanylimidazoles with alpha2 adrenergic activity

Details for Australian Patent Application No. 2001258469 (hide)

Owner Orion Corporation

Inventors Karjalainen, Arja; Karjalainen, Arto; Huhtala, Paavo; Ratilainen, Jari; Lehtimaki, Jyrki; Virtanen, Raimo; Haapalinna, Antti

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001258469

PCT Pub. Number WO01/85698

Priority 20001065 08.05.00 FI

Filing date 7 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 14 April 2005

International Classifications

C07D 233/56 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61P 003/10 Drugs for disorders of the metabolism

A61P 025/00 Drugs for disorders of the nervous system

A61K 031/4164 - 1,3-Diazoles

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001258469

11 August 2005 Standard Patent Sealed

11 January 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001258470

2001258468-RLC/MAC Protocol